Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessme... by Ricardo J. O. Ferreira, Paco M. J. Welsing, Johannes W. G. Jacobs, Laure Gossec, Mwidimi Ndosi, Pedro M. Machado, Désirée van derHeijde, José A. P. daSilva

Get full text

Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? by Désirée van der Heijde, Laure Gossec, Pedro M Machado, Johannes W G Jacobs, Paco M J Welsing, José António Pereira Da Silva, Ricardo J O Ferreira, Cátia Duarte

Get full text

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combin... by Xavier M Teitsma, Wei Yang, Johannes W G Jacobs, Attila Pethö-Schramm, Michelle E A Borm, Amy C Harms, Thomas Hankemeier, Jacob M van Laar, Johannes W J Bijlsma, Floris P J G Lafeber

Get full text

Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protoc... by Matthijs S. van der Leeuw, Paco M. J. Welsing, Maria J. H. de Hair, Johannes W. G. Jacobs, Anne C. A. Marijnissen, Suzanne P. Linn-Rasker, Faouzia Fodili, Reinhard Bos, Janneke Tekstra, Jacob M. van Laar

Get full text